| Molecular formula | C208H344N60O63S2 |
|---|
| Molecular weight | 4757 g/mol |
|---|
| Registered trials | 96 |
|---|
| PubChem CID | 16186200 |
|---|
Researchers looking into corticorelin often want to know what it actually is and how extensively it has been studied. Here is a plain-data summary of its identity and its footprint in registered clinical trials.
What corticorelin is
Corticorelin is a peptide compound (PubChem CID 16186200) with a large polypeptide structure built from a chain of amino acids. Public label information for this compound was not available in the data reviewed for this summary, so specific approved indications, mechanism, and brand names cannot be confirmed here.
What the evidence shows
Corticorelin has been associated with 96 registered clinical trials. Among the studies on record, one completed trial examined the effects of urocortins on forearm arterial blood flow in healthy volunteers. Another completed trial used jugular vein sampling to study hormone levels in the diagnosis of Cushing syndrome. A separate early-phase study looked at interactions between corticotropin-releasing factor and the nociceptin receptor system.
Reported side effects
No FAERS adverse event report data was available for corticorelin in the data reviewed for this summary.
FAQ
Corticorelin is a peptide compound identified in chemical databases under PubChem CID 16186200. Specific label information such as approved indications and mechanism of action was not available in the data reviewed for this summary.
Corticorelin appears in 96 registered clinical trials according to available records. These range from studies on arterial blood flow to hormone sampling for endocrine diagnosis.
Example studies include a completed trial on forearm arterial blood flow in healthy volunteers, a completed trial using jugular vein sampling for hormone levels related to Cushing syndrome, and an early-phase study on corticotropin-releasing factor and nociceptin receptor interactions.
No adverse event report data was available for corticorelin in the data reviewed for this summary, so a side effect pattern cannot be described here.
This summary is based on available registry and label data, and specific label details were not available for corticorelin at the time of review.
This page is an editorial information resource. It does not sell, prescribe, or recommend any medication.
Content is editorial information, not medical advice. Talk to your doctor before any treatment decision.
Sources: PubChem ClinicalTrials.gov
Updated 2026-09-19